China home to 200 mln hypertensive patients

China has more than 200 million hypertensive patients, according to Ma Xiaowei, an official at the National Health and Family Planning Commission of China.

China home to 200 mln hypertensive patients
2015-03-24
Lilly/Boehringer's Diabetes Combination Glyxambi Debuts in US

GLYXAMBI is the first diabetes treatment in the U.S. to combine the dual mechanisms of action of a sodium glucose co-transporter-2 (SGLT2) inhibitor and a dipeptidyl peptidase-4 (DPP-4) inhibitor in a...

2015-03-24
General Office of the State Council issues Guidance onFurther Improving the Building of Rural Medical Workforce

In order to further strengthen the building of rural medical workforce and laid a solid foundation for rural medical and healthcare services,the General Office of the State Council recently issued the...

2015-03-19
Drug Price ControlLiberalization Scheme to Release in April

On March 17, the National Development and Reform Commission (the “NDRC”)held a conference on drug price. Representatives from 10 provinces and municipalities, including Tianjin, Heilongjiang, Anhui,...

2015-03-04
CFDA Issues Technical Guideline for Development and Evaluation of Biosimilars

In order to guide and standardize the development and evaluation of biosimilars and promote the sound development of biomedicine industry, China Food and Drug Administration (CFDA) recently issued the...

2015-02-28
Drug Price Reform Plan to Release in 2015

On 4 March, an official of Pricing Department, the National Development and Reform Commission (the “NDRC”) revealed at thebreak of the conference of pharmaceutical representatives during this year’...

Total 26 Pages  First page  Page up  Page down  Last page

Select

  • 2015
  • 2014
  • 2013
  • 2012